Ameriprise’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
82,010
-5,183
-6% -$98.9K ﹤0.01% 3088
2025
Q4
$2.01M Sell
87,193
-6,955
-7% -$179K ﹤0.01% 2996
2025
Q3
$2.53M Sell
94,148
-5,224
-5% -$125K ﹤0.01% 2889
2025
Q2
$1.67M Sell
99,372
-12,091
-11% -$213K ﹤0.01% 3035
2025
Q1
$1.97M Sell
111,463
-72,677
-39% -$1.46M ﹤0.01% 2912
2024
Q4
$4.47M Buy
184,140
+57,129
+45% +$1.63M ﹤0.01% 2434
2024
Q3
$4.72M Sell
127,011
-16,396
-11% -$611K ﹤0.01% 2413
2024
Q2
$6.83M Sell
143,407
-4,283
-3% -$188K ﹤0.01% 2056
2024
Q1
$5.65M Buy
147,690
+2,773
+2% +$90.2K ﹤0.01% 2275
2023
Q4
$4.52M Sell
144,917
-12,115
-8% -$435K ﹤0.01% 2420
2023
Q3
$6.31M Buy
157,032
+96,147
+158% +$4.5M ﹤0.01% 2100
2023
Q2
$3.2M Sell
60,885
-2,757
-4% -$168K ﹤0.01% 2633
2023
Q1
$4.07M Sell
63,642
-543
-0.8% -$35.4K ﹤0.01% 2456
2022
Q4
$3.12M Sell
64,185
-4,715
-7% -$296K ﹤0.01% 2586
2022
Q3
$4.86M Sell
68,900
-1,313
-2% -$112K ﹤0.01% 2247
2022
Q2
$4.98M Sell
70,213
-244
-0.3% -$15.7K ﹤0.01% 2278
2022
Q1
$5.63M Buy
70,457
+2,617
+4% +$195K ﹤0.01% 2345
2021
Q4
$6.2M Sell
67,840
-2,398
-3% -$257K ﹤0.01% 2316
2021
Q3
$9.03M Sell
70,238
-4,188
-6% -$586K ﹤0.01% 1938
2021
Q2
$11.3M Sell
74,426
-2,024
-3% -$267K ﹤0.01% 1844
2021
Q1
$8.06M Buy
+76,450
New +$7.65M ﹤0.01% 2050
2020
Q3
Sell
-10,109
Closed -$622K 3781
2020
Q2
$622K Sell
10,109
-1,169
-10% -$47.8K ﹤0.01% 3118
2020
Q1
$365K Sell
11,278
-2,026
-15% -$68.3K ﹤0.01% 3236
2019
Q4
$468K Sell
13,304
-532
-4% -$17.6K ﹤0.01% 3351
2019
Q3
$357K Buy
+13,836
New +$421K ﹤0.01% 3408
2019
Q2
Sell
-43,455
Closed -$1.49M 3784
2019
Q1
$1.49M Buy
43,455
+19,113
+79% +$676K ﹤0.01% 2875
2018
Q4
$776K Sell
24,342
-3,360
-12% -$131K ﹤0.01% 3036
2018
Q3
$1.33M Sell
27,702
-15,070
-35% -$617K ﹤0.01% 2966
2018
Q2
$1.33M Buy
+42,772
New +$1M ﹤0.01% 2908
2016
Q1
Sell
-1,232,843
Closed -$8.8M 3857
2015
Q4
$8.8M Sell
1,232,843
-81,077
-6% -$657K 0.01% 1540
2015
Q3
$10.2M Sell
1,313,920
-720,338
-35% -$5.93M 0.01% 1458
2015
Q2
$19.6M Sell
2,034,258
-126,298
-6% -$1.17M 0.01% 1025
2015
Q1
$16.1M Buy
2,160,556
+14,113
+0.7% +$103K 0.01% 1157
2014
Q4
$19.6M Buy
2,146,443
+194,071
+10% +$1.88M 0.01% 982
2014
Q3
$20.8M Buy
1,952,372
+120,681
+7% +$1.43M 0.01% 944
2014
Q2
$30.8M Sell
1,831,691
-5,434
-0.3% -$89.4K 0.02% 765
2014
Q1
$34.5M Sell
1,837,125
-325,222
-15% -$5.24M 0.02% 698
2013
Q4
$35M Sell
2,162,347
-306,044
-12% -$4.09M 0.02% 686
2013
Q3
$33.4M Sell
2,468,391
-454,977
-16% -$5.35M 0.02% 723
2013
Q2
$29.7M Buy
+2,923,368
New +$23.7M 0.02% 760

Other funds holding STAA

Ameriprise's STAA Position: Q1 2026 in Review

Ameriprise reduced its STAAR Surgical (STAA) stake by 5.9% in Q1 2026, selling an estimated $98.9K and leaving 82,010 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3088.

Ameriprise first reported a position in STAA in Q2 2013 and has held it in 40 quarters since. The position peaked at $35M in Q4 2013. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Ameriprise held 82,010 shares of STAAR Surgical worth $1.53M as of Q1 2026.
  • Ameriprise sold 5,183 STAAR Surgical shares in Q1 2026, an estimated $98.9K.
  • STAAR Surgical made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3088 holding.
  • Ameriprise first reported a position in STAAR Surgical in Q2 2013 and has held it in 40 quarters since.
  • Ameriprise's STAAR Surgical position peaked at $35M in Q4 2013.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.